scispace - formally typeset
A

Alok Jha

Researcher at The Feinstein Institute for Medical Research

Publications -  9
Citations -  74

Alok Jha is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Podocyte & Nephrin. The author has an hindex of 3, co-authored 9 publications receiving 42 citations. Previous affiliations of Alok Jha include Mangalayatan University.

Papers
More filters
Journal ArticleDOI

Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.

TL;DR: It is suggested that D PDG1s and DPDG2s developed disorganized actin cytoskeleton as a consequence of disrupted APOL1-miR193a axis, and docking and co-labeling studies suggested an interaction between AP OL1 and CD2AP.
Journal ArticleDOI

Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu

TL;DR: In this paper, the role of K+ efflux in the activation of inflammasomes in APOL1 risk and non-risk milieus was investigated, where alterations in the structural configurations of channels and activation of nucleotide-binding domain were evaluated.
Journal ArticleDOI

Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu

TL;DR: Docking, protein-protein interaction, and immunoprecipitation studies with anti-autophagy related gene (ATG) 14L, anti-UV radiation resistance-associated gene (UVRAG), or Rubicon antibodies suggested the formation of ATG14L complex I and UVRAG complex II in G0- podocytes and theformation of Rubicon complex III in G1- and G2-podocytes.
Journal ArticleDOI

EDA2R mediates podocyte injury in high glucose milieu

TL;DR: It is demonstrated that high glucose increases EDA2R expression in kidney cells and that Eda2R induces podocyte apoptosis and dedifferentiation in high glucose milieu partially through enhanced ROS generation.
Journal ArticleDOI

MiR193a Modulation and Podocyte Phenotype

TL;DR: Interactions between miR193a and YY1/WT1/Sox2/VDR/APOL1 3′ UTR region and transcription factors and their effects on podocytes’ molecular phenotype suggest that down-regulation of miR 193a could be used to enhance the expression of podocyte differentiating markers as a therapeutic strategy.